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LETTER FROM THE PRESIDENT 
The Agenda for ASBMT 
Every president comes into office with goals and an 
agenda of things to accomplish during his or her term of 
office. Mine are in several specific areas where ASBMT is 
doing well, but can do even better. 
First, I want to accelerate our membership growth among 
the basic scientists in our field. One of the original purposes of 
ASBMT when it was founded in 1993 was to provide a forum 
where those engaged in laboratory research and clinical 
research could come together to speed the transfer of knowl- 
edge. Over these past several years we've done well attracting 
and addressing the needs of the clinician. We now need to step 
up recrtfitment ofthose working in research laboratories. 
Second, like every organization, we need to recruit the 
young people in our field. We are doing that in a number of 
ways with scholarship awards for young investigators (we now 
have four of them!), editorial awards for new investigators 
who publish in our journal, travel grants for our annual meet- 
ing, and substantially reduced ues for fellows-in-training. 
Third, I won't be happy if we don't at least double the 
number of abstracts submitted for our annual meeting. The 
Tandem BMT Meetings, held jointly with the IBMTR/  
ABMTR, have been a phenomenal success with record num- 
bers of abstracts each year. We're working now to capitalize 
on that success by casting the net out much farther for 
abstracts for next February in Orlando. The number of ses- 
sions set aside for oral presentation of abstracts will be sub- 
stantially increased. 
Fourth, we are embarking on a tong-term plan for our 
monthly journal, Biology of Blood and Marrow Transplantation. 
I hope you agree that BBMT is presenting the best clinical 
and basic science papers in our field. I've appointed a "Task 
Force on BBMT 2003" to help chart our course for the next 
several years. The chair is former co-editor Karl Blume, who 
will be working closely with our current editor, Bob Korn- 
gold, and our Publications Committee chair, Dan Weisdorf. 
Finally, we need to achieve financial stability for ASBMT. 
We started out in 1993 with no bank account, and it's no 
secret hat in the first several years we were skating very close 
to insolvency. Fortunately, today we are no longer at the 
financial brink, but we're also not yet operating in a financial 
comfort zone. We need to identify new sources of revenues so 
that we can accomplish the things that need to be done. 
OUR ACCOMPLISHMENTS 
I hasten to add, we've shown we can accomplish a lot 
with limited resources. In addition to a first-class journal 
and a popular annual meet ing. . .  
We have developed guidelines for BMT clinical centers 
and guidelines for training, which are being used by 
FAHCT in its voluntary accreditation activities. 
FAHCT, itself, is incredibly successful and important. 
The Foundation for Accreditation of Hematopoietic Cell 
Therapy may well be protecting us from being undercut by 
federal regulation. 
The Board of Directors has revised the way in which we 
elect our Society's leaders. We now have designated seats on 
the Board to make sure that all segments of our membership 
are represented, and we are doing this in a way that puts the 
best leaders, not just the best-known clinicians, on the 
Board. Last year's president, J im Armitage, deserves the 
most credit for the reorganization of the Board, and I think 
it has been absolutely necessary for our success. 
The evidence-based reviews for BMT are being accom- 
plished and it seems that the target audiences are eagerly 
receiving them. 
We have brought a lot of people, in addition to physi- 
cians and investigators, into our society. At our annual meet- 
ings there are parallel conferences for BMT nurses, trans- 
plant center administrators, and, this year for the first time, 
BMT pharmacists. 
Our councils and committees are moving aggressively 
on a variety of programs. 
YOUR PRIORITIES 
Recently ou were invited by e-mail to participate in a 
membership opinion survey that was posted on our Web 
site. The questionnaire briefly asked your opinions about 
our annual meeting, our journal, and other activities in areas 
such as guidelines and standards, research support, regula- 
tory and legislative affairs, and managed care. 
We had a highly satisfactory esponse to the survey, and 
your opinions were helpful to the Board of Directors when 
they gathered in Chicago in June for a one-day strategic 
planning retreat. We will be reporting to you on the results 
of that opinion survey and the goals that have been decided 
by the Board based on your answers to the survey. 
I look forward in the months ahead to telling you about 
our progress in accomplishing the priorities that you told us 
are important. 
Richard J. O'Reilly, M.D. 
President 
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